ZVRAZevra Therapeutics, Inc.
$11.00+7.9% 1Y
$11.00
$8.1052 weeks$14.74
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +4% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ZVRA is trading
Zevra Therapeutics, Inc. is +7.9% over the past year while the S&P 500 is +18%: 10 points behind the market.
+7.9%
1-year return · S&P 500 +18%
- vs 200-day average
- +3.7%
vs 200-day average · close to trend
- RSI (14)
- 41
RSI (14) · neutral
- Below its 52-week high
- 25%
Below its 52-week high
Details›
- Last close2026-10-08
- $11.00
- 1 monthS&P 500 +1.6%
- −8.5%
- 1 yearS&P 500 +18%
- +7.9%
- 5 yearsS&P 500 +86%
- +18%
- vs 50-day average$11.41
- −3.6%
- 52-week high
- $14.74
- 52-week low
- $8.10
- Annualised volatility
- 58%
| Year | Return |
|---|---|
| 2026 (year to date) | +23% |
| 2025 | +7.4% |
| 2024 | +27% |
| 2023 | +43% |
| 2022 | −47% |
| 2021 | −22% |
| 2020 | +85% |
| 2019 | −79% |
| 2018 | −56% |
| 2017 | +37% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +5.7% |
| Feb | 10 | 5 of 10 | +4.1% |
| Mar | 10 | 3 of 10 | −3.7% |
| Apr | 10 | 3 of 10 | −3.9% |
| May | 10 | 7 of 10 | +1.9% |
| Jun | 10 | 8 of 10 | +11% |
| Jul | 11 | 5 of 11 | −0.48% |
| Aug | 11 | 6 of 11 | +7.9% |
| Sep | 11 | 5 of 11 | −3.0% |
| Oct | 11 | 6 of 11 | −7.3% |
| Nov | 10 | 4 of 10 | +4.6% |
| Dec | 10 | 4 of 10 | −4.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.